Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2000, p. 3317-3322, Vol. 38, No. 9
Sera and Vaccines Central Research
Laboratory1 and The National Reference
Center for Antibiotic Resistance,2 00-725 Warsaw, Poland
Received 10 April 2000/Returned for modification 3 June
2000/Accepted 6 June 2000
Twenty-two vancomycin-resistant enterococcal (VRE) isolates of the
VanA phenotype (21 Enterococcus faecium isolates
and 1 E. faecalis isolate), representative of a large
outbreak that occurred in a hospital in Gda Over the last decade, enterococci
have emerged as very important nosocomial pathogens (19,
21), and this has been attributed, among other factors, to their
broad natural and acquired resistance to antimicrobial agents,
including glycopeptides (vancomycin and teicoplanin). The first
vancomycin-resistant enterococci (VRE), Enterococcus faecium
and E. faecalis, were identified in 1986 in France
(17) and in the United Kingdom (30), and since
then VRE strains have been reported in many countries worldwide
(3, 5, 27). Five different phenotypes of glycopeptide
resistance (VanA to VanE) have been described to date, and the highest
clinical relevance has been assigned to phenotypes VanA and VanB
(9, 11, 17, 18, 24). Enterococcal strains of the VanA
phenotype are highly resistant to vancomycin and moderately or highly
resistant to teicoplanin. This phenotype is inducible and determined by a cluster of genes, three of which, vanH, vanA,
and vanX, are critical for resistance determination.
Together with two regulatory genes, vanR and
vanS, they form a highly conserved
vanRSHAX region of active transposons of the
Tn1546 type (1, 2). Tn1546-like elements are often carried by plasmids (1, 2), and various modifications in different positions of the transposons cause their
remarkable polymorphism (12, 13, 23, 32). The location of
genes responsible for the VanA phenotype within transposons and
plasmids strongly facilitates their horizontal spread among enterococcal strains (1, 2, 12, 13, 23, 32). Numerous nosocomial VRE outbreaks, attributed either to horizontal transfer of
resistance determinants or to clonal dissemination of epidemic strains,
have been reported to date (6, 20, 27, 29, 34).
Here we present the results of the detailed epidemiological analysis of
VRE isolates representative of the outbreak that occurred in the
University Hospital in Gda Clinical isolates.
The first VRE isolate was cultured in the
University Hospital in Gda
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Outbreak of Vancomycin-Resistant Enterococci in a Hospital in
Gda
sk, Poland, due to Horizontal Transfer of Different
Tn1546-Like Transposon Variants and Clonal Spread of
Several Strains
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
sk, Poland, were
studied. All of the isolates demonstrated resistance to a wide variety
of other antimicrobial agents in addition to glycopeptides. Several
lines of evidence suggested that the outbreak most probably consisted of two epidemics that followed the independent introduction of VanA
determinants into two separate hematological wards of the hospital.
This hypothesis is supported by the fact that isolates recovered in
these wards possessed two different polymorphs of the highly conserved
DNA region encompassing the vanRSHAX genes and two distinct
polymorph types of Tn1546-like transposons, which contain
these genes. According to pulsed-field gel electrophoresis data, the outbreak in the adult hematology ward (HW) was highly polyclonal, which suggested a major role for the horizontal
transmission of Tn1546-like elements among nonrelated
strains of E. faecium and E. faecalis in this
environment. On the other hand, the outbreak in the pediatric
hematology ward (PHW) was most probably due to the clonal spread of two
epidemic E. faecium strains, which had exchanged a
plasmid carrying the Tn1546-like transposon. Restriction fragment length polymorphism studies of transposons and their insertion
loci in plasmid DNA have suggested that numerous isolates from both HW and PHW contained two or more copies of
Tn1546-like elements that underwent diversification due to
various genetic modifications. The reported data demonstrated a very
complex epidemiology of the first, and up to now the only, VanA VRE
outbreak characterized in Poland.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
sk, Poland, from 1997 to 1999. Isolates recovered at the beginning of the epidemic were the first VRE
strains described in Poland (14, 25), and to date this has
been the only outbreak caused by VanA enterococci identified and
characterized in Poland.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
sk from the urinary tract infection of
a patient located in the hematology ward (HW) in December 1996. From
the beginning of 1997 to the end of 1999, VRE isolates were recovered
from 128 infected or colonized patients who were hospitalized in the HW (112 patients), the pediatric hematology ward (PHW; 12 patients), and
the intensive care unit (ICU; 4 patients) (26; A. Samet, personal communication).
TABLE 1.
Clinical Enterococcus isolates: selected
clinical data, typing by PFGE, MICs, and mating results
Antimicrobial susceptibility testing. MICs of different antimicrobial agents were evaluated by the agar dilution method according to NCCLS guidelines (22). The following agents were tested: penicillin, ampicillin, gentamicin, streptomycin, tetracycline, and chloramphenicol (Polfa Tarchomin, Warsaw, Poland); vancomycin (Eli Lilly, Indianapolis, Ind.); teicoplanin (Marion Merrell, Denham, United Kingdom); and ciprofloxacin (Bayer, Wuppertal, Germany). E. faecalis ATCC 29212, Staphylococcus aureus ATCC 29213, and E. faecium BM4147 VanA standard strain (1) were used as reference strains.
Resistance transfer (mating). The vancomycin resistance transfer experiment was carried out according to the filter-mating procedure described by Klare et al. (16). E. faecium 64/3 resistant to rifampin and fusidic acid (31) was used as a recipient strain. Transconjugants were selected on the brain heart infusion agar (Oxoid, Basingstoke, United Kingdom) containing rifampin (64 µg/ml; Polfa Tarchomin) or fusidic acid (64 µg/ml; Leo Pharmaceutical Products, Ballerup, Denmark) and vancomycin (32 µg/ml).
PFGE typing. Total DNA preparations embedded in 0.75% agarose plugs (InCert Agarose; FMC Bioproducts, Rockland, Maine) were digested with SmaI restriction enzyme (Takara, Otsu, Japan) and separated in a 1% agarose gel (Pulsed Field-Certified; Bio-Rad, Hercules, Calif.) using a CHEF DRII system (Bio-Rad). DNA purification and digestion were performed according to the method of Clark et al. (5), and the electrophoresis was run under conditions described by de Lencastre et al. (7). PFGE results were interpreted in accordance with the criteria proposed by Tenover et al. (28).
Detection of the vanA gene.
Total DNA was
purified from the isolates using the Genomic DNA Prep Plus kit (A&A
Biotechnology, Gda
sk, Poland). The vanA gene was
detected by specific PCR with two different pairs of primers (5,
8) in a GeneAmp 2400 thermocycler (Perkin-Elmer, Norwalk, Conn.).
DNA isolated from the E. faecium BM4147 VanA standard strain
(1) was used as a control.
Amplification of Tn1546-like transposons and vanRSHAX regions by L-PCR. Tn1546-like elements were amplified using the Expand Long Template PCR System (Boehringer-Mannheim, Mannheim, Germany), and total DNA preparations of the isolates as templates. A single oligonucleotide, primer 1 (23), complementary to the transposon-flanking inverted repeats was used as a primer. The buffering conditions were as recommended by the manufacturer, and cycling was performed as described by Palepou et al. (23) with the annealing temperature decreased to 60°C. Subsequently, the amplified Tn1546-like transposons served as templates for long PCR (L-PCR) of vanRSHAX gene-containing regions. Primers 2 and 3 (23) were used in the reactions, and these were run under conditions according to the method of Palepou et al. (23), with the annealing temperature decreased to 56°C and the initial elongation time reduced to 4 min. The amplifications were carried out in a GeneAmp 2400 thermocycler (Perkin-Elmer), and L-PCR products were electrophoresed in 0.8% agarose gels (SeaKem; FMC Bioproducts). DNA purified from the E. faecium BM4147 VanA standard strain (1) was used as a control.
Restriction fragment length polymorphism (RFLP) analysis of Tn1546-like transposons and their vanRSHAX regions. The L-PCR products containing Tn1546-like elements were digested independently with ClaI (Takara) (23) and EcoRI (MBI Fermentas, Vilnius, Lithuania) restriction enzymes, and the resulting DNA fragments were separated in 1% agarose gels (SeaKem). The vanRSHAX amplicons were cut with the DdeI restrictase (Promega, Madison, Wis.) (23) and electrophoresed in 2% agarose gels (SeaKem).
RFLP analysis of Tn1546 loci. For plasmid DNA purification, bacterial cells were predigested with lysozyme (0.5 mg/ml; Sigma Chemical Co., St. Louis, Mo.), and plasmids were isolated from the spheroplasts by the alkaline lysis method (4) using a Plasmid Midi Kit (Qiagen, Hilden, Germany). DNA preparations were digested with EcoRI (MBI Fermentas), electrophoresed in 1% agarose gels (SeaKem), and blotted onto a Hybond-N membrane (Amersham Pharmacia Biotech, Little Chalfont, United Kingdom) for hybridization with the Tn1546 probe. The L-PCR amplicon of the Tn1546 transposon present in the E. faecium BM4147 VanA standard strain (1) was used as the probe. Prior to labeling, the PCR product was purified using the QIAquick PCR Purification Kit (Qiagen); probe labeling, hybridization, and signal detection were performed with the ECL Direct Nucleic Acid Labeling and Detection systems (Amersham Pharmacia Biotech). Plasmid DNA isolated from the E. faecium BM4147 strain (1) was used as a control.
| |
RESULTS |
|---|
|
|
|---|
Antimicrobial susceptibility testing.
MICs are presented in
Table 1. All of the isolates were characterized by high MICs of
vancomycin (MICs, 256 to >512 µg/ml) and teicoplanin (MICs, 32 to 256 µg/ml), and all were found to be resistant to ciprofloxacin
(MICs, 32 to 256 µg/ml). The E. faecium isolates were
uniformly resistant to penicillin (MICs,
128 µg/ml) and ampicillin
(MICs, 32 to >128 µg/ml); none of the isolates was resistant to
chloramphenicol (MICs, 4 to 16 µg/ml). Various susceptibility
phenotypes were observed regarding aminoglycosides and tetracycline.
Nine isolates demonstrated the HLSR (high-level streptomycin
resistance) phenotype (streptomycin MICs,
2,048 µg/ml; gentamicin
MICs, 16 to 64 µg/ml), six isolates were of the HLGR (high-level
gentamicin resistance) phenotype (gentamicin MICs,
512 µg/ml;
streptomycin MICs, 32 to 128 µg/ml), and seven isolates
expressed the HLAR (high-level aminoglycoside resistance) phenotype (streptomycin MICs,
2,048 µg/ml; gentamicin MICs,
512 µg/ml). Seven isolates were susceptible to tetracycline
(MICs, 0.25 to 1 µg/ml), whereas the remaining ones were
resistant to this antibiotic (MICs, 32 to 128 µg/ml).
Mating.
Results of mating are presented in Table 1. All but
three isolates (E. faecium 1641 and 7953 and E. faecalis 7946) produced vancomycin-resistant transconjugants. The
efficiency of conjugation ranged from 10
3 to
10
9 and was significantly higher in the group of
isolates from the PHW (data not shown). Evaluation of MICs has revealed
that in several cases resistance to streptomycin (isolates 1639, 7947, and 7948) or to tetracycline (isolates 7950 and 7952) was cotransferred with the glycopeptide resistance (data not shown).
Typing. Results of PFGE typing are presented in Table 1. The analysis distinguished eight different PFGE types among all 21 E. faecium isolates (types A to H). Eight isolates obtained from patients in the HW were classified into six distinct PFGE types. Only two pairs of isolates from the HW produced identical PFGE patterns, including one from the isolates obtained from the same patient (7948 and 7950, PFGE type G). Isolates of the second pair (7947 and 7953, PFGE type F1), were found to be closely related to the only studied isolate from the ICU (7949, PFGE type F2).
On the other hand, 12 E. faecium isolates collected in the PHW were split into two equal groups of closely related isolates (PFGE types D and E) and could be further classified to several subtypes (D1 to D5 and E1 to E4). Two isolates from different patients (3135 and 3136) and one from the environment (3139) were found to be indistinguishable by PFGE (subtype E1).Detection of the vanA gene. The vanA gene was detected in all the isolates with the use of two pairs of specific PCR primers. The amplification carried out with primers A1 and A2 (8) produced DNA molecules of the expected size of about 730 bp, whereas amplicons of the expected size of about 1 kb were obtained in the reaction performed according to the method of Clark et al. (5) (results not shown).
RFLP analysis of Tn1546-like transposons.
Tn1546-like elements were amplified by L-PCR, and products
of the expected size of about 10 kb were obtained for all of the analyzed isolates. Results of their restriction analysis
(ClaI digests) are shown in Fig.
1. Transposons amplified from 10 isolates recovered in the HW and the ICU (E. faecium and
E. faecalis) produced RFLP patterns that were different from
that obtained for the original Tn1546 (23).
In several cases (isolates 1641, 7946, 7948, 7950, and 7952) these
patterns were complex and contained DNA bands of a nonproportional
intensity, which could suggest the presence of two or more transposon
copies of different RFLP types in a single isolate. Nevertheless,
obvious similarities between the patterns could be observed.
Transposons of E. faecium isolates 1639, 1640, and 7949 were
characterized by identical, relatively simple RFLP patterns, and all of
their bands were also included in the patterns specific for
isolates 7947 and 7953. Transposons amplified from the E. faecium isolate 7952 and the E. faecalis isolate 7946 produced the same RFLP patterns, which were very similar to those
characteristic for the E. faecium isolates 7948 and 7950. Several common DNA bands could be found in all RFLP patterns of
Tn1546-like elements of the isolates from the HW and the
ICU.
|
RFLP analysis of vanRSHAX regions.
Figure
2 presents results of DdeI
digestion of DNA amplicons of about 4.4 kb encompassing
vanRSHAX genes, which were obtained in nested L-PCR
reactions with the use of transposon templates. These regions of all
the isolates from the HW and the ICU produced an identical RFLP pattern
that was different than that obtained for the homologous fragment of
the original Tn1546 element (23). The
vanRSHAX DNA amplified from all the PHW isolates were
found to be of the other DdeI RFLP type, and this one was
indistinguishable from Tn1546.
|
RFLP analysis of the Tn1546 locus.
EcoRI-digested plasmids purified from clinical isolates or
their transconjugants were used to study the polymorphism of DNA regions (or entire plasmids), in which Tn1546-like elements
were inserted. The isolates (as well as transconjugants) were found to
contain numerous plasmid molecules of different size, sequence and
abundance, and their isolate-specific combinations have determined a
high complexity and diversity of restriction patterns of plasmid DNA even among isolates belonging to the same PFGE type (results not
shown). Results of hybridization of plasmid DNA with the
Tn1546 probe are presented in Fig.
3. The Tn1546 hybridization
patterns of the isolates recovered in the HW and the ICU revealed a
high degree of diversity. A single band common for the majority of patterns was most probably the internal EcoRI restriction
fragment of one of the Tn1546-like element variants that was
spread within this population. Similarities of the entire RFLP patterns
could also be observed between particular isolates (e.g., isolates 7949 and 7953 and isolates 1639 and 7948).
|
| |
DISCUSSION |
|---|
|
|
|---|
In a 1996 survey of antimicrobial susceptibility of enterococci
isolated in Polish hospitals, no vancomycin-resistant strains of
E. faecium or E. faecalis were detected
(15). Numerous isolations of VRE in the University Hospital
in Gda
sk in 1997 to 1999 indicated that the first nosocomial
outbreak of VRE had occurred in the country (14, 25). The
outbreak was caused by E. faecium as only a single
vancomycin-resistant isolate of E. faecalis was identified
in the hospital during this time. All of the collected isolates
demonstrated the VanA phenotype (9) of glycopeptide resistance, and this was confirmed by PCR detection of the
vanA gene in groups of representative isolates (references
14 and 25 and this study). The
isolates were found to be multidrug resistant, uniformly demonstrating
additional resistance to penicillins, ciprofloxacin, and high
concentrations of aminoglycosides.
Several lines of evidence obtained in this study of representative isolates suggested that the VanA phenotype was most likely selected by at least two independent events within the hospital enterococcal population. This hypothesis was mostly supported by the observation of two distinct RFLP types of the highly conserved DNA region encompassing the vanRSHAX genes that are critical for the resistance phenotype. The revealed dichotomy of vanRSHAX regions strictly correlated with two general similarity groups in the RFLP of the entire Tn1546-like transposons containing van genes; however, these elements demonstrated a remarkable degree of diversity. The distribution of isolates containing the two main types of VanA determinants suggested that the selection events had occurred in two different hematological wards (HW and PHW), which are located in separate buildings of the hospital. Therefore, it is very likely that the collected isolates represented two rather distinct VRE outbreaks that occurred at the same time in the center.
The outbreak in the HW was highly polyclonal, as demonstrated by the diversity of the distinguished E. faecium PFGE types and by the isolation of the single vancomycin-resistant E. faecalis strain. The observed relatedness of some of the E. faecium isolates (PFGE type F) suggested, however, that clonal spread has also occurred in the HW and that one of the strains was probably exported from the HW to the ICU. (The small number of isolates studied has precluded the possibility of evaluating the extent of the clonal dissemination in the ward.) It may be postulated that originally a single variant of the Tn1546-like transposon was spread among the nonrelated enterococcal strains circulating in the HW. This hypothesis is supported by the fact that the HW isolates, collected over a period of approximately 3 years, produced identical RFLP patterns for the vanRSHAX region and related RFLP patterns of Tn1546-like transposons. The certain degree of diversity observed within the transposon RFLP most probably reflected multiplication of the elements, in particular strains and differentiation of the resulting copies by various genetic events such as point mutations, insertions, or deletions within their less-conserved parts (13, 23, 31, 32). The remarkable heterogeneity of transposon loci RFLP patterns characteristic for the HW isolates has been most likely due to transposition of the Tn1546-like elements to a high variety of plasmid molecules, some of which could be then further transmitted by conjugation to other enterococcal strains.
The outbreak in the PHW was most probably due to the clonal spread of two different E. faecium strains (represented by isolates of PFGE types D and E) that were not related to those in the HW. Minor differences in PFGE patterns observed in both types revealed the ongoing evolutionary diversification process within their populations. Isolates of the two types produced identical RFLP patterns of vanRSHAX regions, entire Tn1546-like transposons, and transposon loci in plasmid DNA. This indicated that most probably a single variant of the transposon was transmitted along with a plasmid from one of the epidemic strains to the other. This element is likely identical or closely related to the original Tn1546 transposon (23); however, it is located in a different plasmid than the one specific for the BM4147 VanA standard strain (1). Modifications of the transposon RFLP observed in some isolates of the group were probably due to the element's duplication and recombination, and this was reflected also by the heterogeneity of Tn1546 insertion loci RFLP patterns in these isolates.
Numerous previous reports have documented the majority of the epidemiological phenomena demonstrated by the present study. Multiple selection events (33), transposition to different replicons (1, 2, 6), plasmid-mediated horizontal transfer (34), and clonal dissemination of epidemic strains (20, 29) were revealed as major factors of vancomycin resistance spread in enterococcal populations. However, in most cases the parallel occurrence of all of these mechanisms was reported either in multicenter studies (12, 23, 29) or studies in which isolates of both human and nonhuman sources were compared (31, 32). Data presented here demonstrate the complexity of the epidemiological situation concerning VRE that may occur in a single medical center. Analysis of a small group of representative isolates has shown that concurrent outbreaks in two different wards of the hospital commenced following more than one independent selection event for acquisition of the VanA determinants. Thus, the developing outbreaks consisted of transmission of plasmids carrying the transposon-located resistance genes, followed by clonal dissemination of the strains. Our understanding of these outbreaks has been subsequently getting more complicated due to transposon multiplication and modification, insertion of copies to other plasmids, and their consequent further spread.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to
ukasz Naumiuk, Marek Bronk, and Alfred
Samet from the University Hospital in Gda
sk for the VRE isolates and clinical data. We also thank Patrice Courvalin who kindly provided
E. faecium BM4147, Wolfgang Witte for the E. faecium 64/3 strain, Teresa Kami
ska for her excellent
technical assistance, and Stephen Murchan for critical reading of the manuscript.
This study was partially supported by the U.S.-Poland Maria
Sk
odowska-Curie Joint Fund II, MZ/NIH-98-324.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Sera and Vaccines Central Research Laboratory, ul. Chelmska 30/34, 00-725 Warsaw, Poland. Phone: (48) 22-841-33-67. Fax: (48) 22-841-29-49. E-mail: kawalec{at}urania.il.waw.pl.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arthur, M.,
C. Molinas,
F. Depardieu, and P. Courvalin.
1993.
Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
J. Bacteriol.
175:117-127 |
| 2. |
Arthur, M., and P. Courvalin.
1993.
Genetics and mechanisms of glycopeptide resistance in enterococci.
Antimicrob. Agents Chemother.
37:1563-1571 |
| 3. |
Bell, J. M.,
J. C. Paton, and J. Turnidge.
1998.
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
J. Clin. Microbiol.
36:2187-2190 |
| 4. |
Birnboim, H. C., and J. Doly.
1979.
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res.
7:1513-1523 |
| 5. |
Clark, N.,
R. Cooksey,
B. Hill,
J. Swenson, and F. Tenover.
1993.
Characterization of glycopeptide-resistant enterococci from U.S. hospitals.
Antimicrob. Agents Chemother.
37:2311-2317 |
| 6. | de Lencastre, H., A. E. Brown, M. Chung, D. Armstrong, and A. Tomasz. 1999. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City hospital. Microb. Drug Resist. 5:113-129[Medline]. |
| 7. | de Lencastre, H., E. P. Severina, R. B. Roberts, B. N. Kreiswirth, and A. Tomasz. 1996. Testing the efficacy of a molecular surveillance network: methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) genotypes in six hospitals in the metropolitan New York City area. The BARG Initiative Pilot Study Group. Bacterial Antibiotic Resistance Group. Microb. Drug Resist. 2:343-351[Medline]. |
| 8. | Dutka-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27[Abstract]. |
| 9. | Evers, S., P. E. Reynolds, and P. Courvalin. 1994. Sequence of the vanB and ddl genes encoding D-alanine:D-lactate and D-alanine:D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583. Gene 140:97-102[CrossRef][Medline]. |
| 10. |
Facklam, R., and M. D. Collins.
1989.
Identification of Enterococcus species isolated from human infections by a conventional test scheme.
J. Clin. Microbiol.
27:731-734 |
| 11. |
Fines, M.,
B. Perichon,
P. Reynolds,
D. F. Sahm, and P. Courvalin.
1999.
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.
Antimicrob. Agents Chemother.
43:2161-2164 |
| 12. |
Handwerger, S.,
J. Skoble,
L. F. Discotto, and M. J. Pucci.
1995.
Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States.
Antimicrob. Agents Chemother.
39:362-368 |
| 13. | Handwerger, S., and J. Skoble. 1995. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 39:2446-2453[Abstract]. |
| 14. |
Hryniewicz, W.,
K. Szczypa,
M. Bronk,
A. Samet,
A. Hellmann, and K. Trzci ski.
1999.
First report of vancomycin-resistant Enterococcus faecium isolated in Poland.
Clin. Microbiol. Infect.
5:503-505[Medline].
|
| 15. |
Hryniewicz, W.,
T. Zar ba, and M. Kawalec.
1998.
Susceptibility patterns of Enterococcus spp. isolated in Poland during 1996.
Int. J. Antimicrob. Agents
10:303-307[CrossRef][Medline].
|
| 16. | Klare, I., E. Collatz, S. Al-Obeid, J. Wagner, A. C. Rodloff, and W. Witte. 1992. Glykopeptidresistenz bei Enterococcus faecium aus Besiedlungen und Infectionen von Patienten aus Intensivstationen Berliner Kliniken und einem Transplantationszentrum. ZAC Zschr. Antimikrob. Antineoplast. Chemother. 10:45-53. |
| 17. | Leclercq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161[Medline]. |
| 18. |
Leclercq, R.,
S. Dutka-Malen,
J. Duval, and P. Courvalin.
1992.
Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.
Antimicrob. Agents Chemother.
36:2005-2008 |
| 19. | Moellering, R. C., Jr. 1992. Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis. 14:1173-1178[Medline]. |
| 20. | Morrison, D., N. Woodford, and B. Cookson. 1995. Epidemic vancomycin-resistant Enterococcus faecium in the UK. Clin. Microbiol. Infect. 1:146-147[Medline]. |
| 21. | Murray, B. E. 1998. Diversity among multidrug-resistant enterococci. Emerg. Infect. Dis. 4:37-47[Medline]. |
| 22. | National Committee for Clinical Laboratory Standards. 1999. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M100-S9, 5th ed. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement, vol. 19, no. 1. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 23. |
Palepou, M. I.,
A. A. Adebiyi,
C. H. Tremlett,
L. B. Jensen, and N. Woodford.
1998.
Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci.
J. Antimicrob. Chemother.
42:605-612 |
| 24. | Perichon, B., P. Reynolds, and P. Courvalin. 1997. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob. Agents Chemother. 41:2016-2018[Abstract]. |
| 25. | Samet, A., M. Bronk, A. Hellmann, and J. Kur. 1999. Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland. J. Hosp. Infect. 41:137-143[CrossRef][Medline]. |
| 26. | Samet, A., M. Bronk, A. Hellmann, J. Juszczyk, and J. Kur. 2000. Epidemiology of glycopeptide resistant Enterococcus faecium in a hematology unit. Presented at the 10th European Congress of Clinical Microbiology and Infectious Diseases [ESCMID], Stockholm, Sweden 28-31 May 2000. Clin. Microbiol. Infect. 6(Suppl. 1):128 (MoP206). |
| 27. |
Suppola, J. P.,
E. Kolho,
S. Salmenlinna,
E. Tarkka,
J. Vuopio-Varkila, and M. Vaara.
1999.
vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.
J. Clin. Microbiol.
37:3934-3939 |
| 28. | Tenover, F. C., R. Arbeit, V. Goering, P. Mickelsen, B. M. Murray, D. Pershing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239[Medline]. |
| 29. |
Thal, L.,
S. Donabedian,
B. Robinson-Dunn,
J. W. Chow,
L. Dembry,
D. B. Clewell,
D. Alshab, and M. J. Zervos.
1998.
Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period.
J. Clin. Microbiol.
36:3303-3308 |
| 30. | Uttley, A. H. C., R. C. George, J. Naidoo, N. Woodford, A. P. Johnson, C. H. Collins, D. Morrison, A. J. Gilfillan, L. E. Fitch, and J. Heptonstall. 1989. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol. Infect. 103:173-181[Medline]. |
| 31. | Werner, G., I. Klare, and W. Witte. 1997. Arrangement of the vanA gene cluster in enterococci of different ecological origin. FEMS Microbiol. Lett. 155:55-61[CrossRef][Medline]. |
| 32. |
Woodford, N.,
A. M. Adebiyi,
M. I. Palepou, and B. D. Cookson.
1998.
Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources.
Antimicrob. Agents Chemother.
42:502-508 |
| 33. | Woodford, N., P. R. Chadwick, D. Morrison, and B. D. Cookson. 1997. Strains of glycopeptide-resistant Enterococcus faecium can alter their van genotypes during an outbreak. J. Clin. Microbiol. 35:2966-2968[Abstract]. |
| 34. |
Woodford, N.,
D. Morrison,
A. P. Johnson,
V. Briant,
R. C. George, and B. Cookson.
1993.
Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci.
J. Clin. Microbiol.
31:653-658 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|